Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CGTX
#3362
Cognition Therapeutics, Inc. Common Stock
1.0
9
-5.22%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-5.22%
Aylık değişim
-18.66%
6 aylık değişim
-58.87%
Yıllık değişim
+142.22%
Önceki kapanış
1.1
5
Open
1.0
9
Bid
Ask
Low
1.0
9
High
1.0
9
Hacim
16
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
CGTX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
41.55 M
61.97 M
61.99 M
73.47 M
88.27 M
—
Valuation ratios
Enterprise value
-2.54 M
18.45 M
9.66 M
12.02 M
79.84 M
119.97 M
Price to earnings ratio
-0.49
-0.82
-0.59
-0.48
-3
-4.89
Price to sales ratio
-90.39
-142.89
—
—
—
—
Price to cash flow ratio
0.65
0.98
0.61
0.49
2.54
4.62
Price to book ratio
0.18
1.49
0.26
0.27
1.08
3.1
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.36
-0.26
-0.36
-0.34
-0.11
-1.08
Return on equity %
-0.69
-0.42
-0.69
-0.96
-0.13
-2.2
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.11
2.65
2.09
1.54
6.44
12.73
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.18
-0.21
-0.16
-0.09
-0.08
-0.54
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.58
0.63
0.27
0.17
0.58
1.65
Net current asset value per share
0.7
0.74
0.37
0.31
0.64
2.06
Tangible book value per share
0.38
0.47
0.2
0.11
0.54
1.32
Working capital per share
0.37
0.46
0.19
0.11
0.54
1.3
Book value per share
0.38
0.47
0.2
0.11
0.54
1.32
Haberler
Cognition Therapeutics, Lewy cisimcikli demans ilacı için FDA ile görüştü
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Cognition’ın DLB ilacı faz 2 çalışmasında olumlu sonuçlar gösterdi
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics genişletilmiş erişim programında hasta kaydını tamamladı
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics, Alzheimer hastalığı ilacı için Faz 3 planlarını açıkladı
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Cognition Therapeutics, Alzheimer ilacı denemesi için hasta kaydını tamamladı
Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?